NM_001164508.2(NEB):c.21736-19TC[4] AND Nemaline myopathy 2
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Nov 8, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003051324.2
Allele description [Variation Report for NM_001164508.2(NEB):c.21736-19TC[4]]
NM_001164508.2(NEB):c.21736-19TC[4]
Condition(s)
Assertion and evidence details
Last Updated: Feb 20, 2024